← Leaderboards
Eric S Zhou
Dana-Farber Cancer Inst
$89,000
Attributed
$178,000
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $89K · FY2021–22$100K$75K$50K$25K$0
'21
'22
Funding mix
By agency
NIH$178,000 · 1
By mechanism
R03$178,000 · 1
Top collaborators
- Kira O. Bona2 shared
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Christopher John Recklitis$2,475,646
- Katie A. Greenzang$760,891
- Kira O. Bona$1,544,325
- Daphne A. Haas-Kogan$5,585,485
- Yana Pikman$885,600
Others in their field
Other Emerging Leaders on “Acceptability And Feasibility”
- Chanza Baytop · Westat, Inc.$271,217,917
- Ana-Maria Vranceanu · Massachusetts General Hospital$15,621,271
- Nathalie Moise · Columbia University Health Sciences$8,346,255
- Ewa Karina Czyz · University Of Michigan At Ann Arbor$6,738,437
- Evan Michael Graboyes · Medical University Of South Carolina$6,374,251
- Soumitri Sil · Emory University$6,121,427
Research focus
Acceptability And FeasibilityDana-Farber Cancer InstituteAcute Lymphocytic LeukemiaActigraphyAcuteAnxietyBehavioralCancer PatientCancer TherapyAffectAntineoplastic ProtocolsChemotherapyChemotherapy-Oncologic ProcedureChildChildhoodChildhood Acute Lymphocytic LeukemiaChronic InsomniaClinical CareClinical PracticeClinical Trial Protocol DocumentComorbidityCare DeliveryCaringDesign